Richard A. Lafayette, M.D. – FDA Inspection, Mar 4, 2026

Record Details

This FDA Inspection record concerns Richard A. Lafayette, M.D., with an inspection on March 4, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Richard A. Lafayette, M.D.
Inspection Date: March 4, 2026
Product Type: Human Drugs
Office: San Francisco District Office
Person: Kristin M. Abaonza (FDA Associated Person)

View Company Profile

ID · 83fae200-15ca-4542-ab37-f4da145499e7

Inspection Facts

Inspection number: 1305848
FDA center: Human Drugs
Project area: Bioresearch Monitoring: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Richard A. Lafayette, M.D.

FDA Inspection

Richard A. Lafayette, M.D.March 4, 2026